273 related articles for article (PubMed ID: 28891516)
1. Effects of donepezil on liver and kidney functions for the treatment of Alzheimer's disease.
Erbayraktar Z; Evlice A; Yener G; Ulusu NN
J Integr Neurosci; 2017; 16(3):335-346. PubMed ID: 28891516
[TBL] [Abstract][Full Text] [Related]
2. A randomized, double-blind, placebo-controlled study of the efficacy and safety of donepezil in patients with Alzheimer's disease in the nursing home setting.
Tariot PN; Cummings JL; Katz IR; Mintzer J; Perdomo CA; Schwam EM; Whalen E
J Am Geriatr Soc; 2001 Dec; 49(12):1590-9. PubMed ID: 11843990
[TBL] [Abstract][Full Text] [Related]
3. 3-year study of donepezil therapy in Alzheimer's disease: effects of early and continuous therapy.
Winblad B; Wimo A; Engedal K; Soininen H; Verhey F; Waldemar G; Wetterholm AL; Haglund A; Zhang R; Schindler R
Dement Geriatr Cogn Disord; 2006; 21(5-6):353-63. PubMed ID: 16508298
[TBL] [Abstract][Full Text] [Related]
4. Serum adipokine levels modified by donepezil treatment in Alzheimer's disease.
Pákáski M; Fehér A; Juhász A; Drótos G; Fazekas OC; Kovács J; Janka Z; Kálmán J
J Alzheimers Dis; 2014; 38(2):371-7. PubMed ID: 23979024
[TBL] [Abstract][Full Text] [Related]
5. Perspectives in the management of Alzheimer's disease: clinical profile of donepezil.
Rogers SL
Dement Geriatr Cogn Disord; 1998; 9 Suppl 3():29-42. PubMed ID: 9853200
[TBL] [Abstract][Full Text] [Related]
6. Additional donepezil treatment for patients with geriatric depression who exhibit cognitive deficit during treatment for depression.
Inoue J; Hoshino R; Nojima H; Ishida W; Okamoto N
Psychogeriatrics; 2016 Jan; 16(1):54-61. PubMed ID: 25919986
[TBL] [Abstract][Full Text] [Related]
7. Donepezil-related toxic hepatitis.
Dierckx RI; Vandewoude MF
Acta Clin Belg; 2008; 63(5):339-42. PubMed ID: 19186568
[TBL] [Abstract][Full Text] [Related]
8. Acetylcholinesterase inhibitors and sleep architecture in patients with Alzheimer's disease.
Cooke JR; Loredo JS; Liu L; Marler M; Corey-Bloom J; Fiorentino L; Harrison T; Ancoli-Israel S
Drugs Aging; 2006; 23(6):503-11. PubMed ID: 16872233
[TBL] [Abstract][Full Text] [Related]
9. Donepezil: a review.
Seltzer B
Expert Opin Drug Metab Toxicol; 2005 Oct; 1(3):527-36. PubMed ID: 16863459
[TBL] [Abstract][Full Text] [Related]
10. Efficacy and safety of donepezil in patients with more severe Alzheimer's disease: a subgroup analysis from a randomized, placebo-controlled trial.
Feldman H; Gauthier S; Hecker J; Vellas B; Xu Y; Ieni JR; Schwam EM;
Int J Geriatr Psychiatry; 2005 Jun; 20(6):559-69. PubMed ID: 15920715
[TBL] [Abstract][Full Text] [Related]
11. Donepezil versus vitamin E in Alzheimer's disease: Part 2: mild versus moderate-severe Alzheimer's disease.
Onofrj M; Thomas A; Luciano AL; Iacono D; Di Rollo A; D'Andreamatteo G; Di Iorio A
Clin Neuropharmacol; 2002; 25(4):207-15. PubMed ID: 12151908
[TBL] [Abstract][Full Text] [Related]
12. Long-term safety and efficacy of donepezil in patients with severe Alzheimer's disease: results from a 52-week, open-label, multicenter, extension study in Japan.
Homma A; Imai Y; Tago H; Asada T; Shigeta M; Iwamoto T; Takita M; Arimoto I; Koma H; Takase T; Ohbayashi T
Dement Geriatr Cogn Disord; 2009; 27(3):232-9. PubMed ID: 19246907
[TBL] [Abstract][Full Text] [Related]
13. Long-term donepezil treatment in 565 patients with Alzheimer's disease (AD2000): randomised double-blind trial.
Courtney C; Farrell D; Gray R; Hills R; Lynch L; Sellwood E; Edwards S; Hardyman W; Raftery J; Crome P; Lendon C; Shaw H; Bentham P;
Lancet; 2004 Jun; 363(9427):2105-15. PubMed ID: 15220031
[TBL] [Abstract][Full Text] [Related]
14. Significance of syncope in patients with Alzheimer's disease treated with cholinesterase inhibitors.
Bordier P; Garrigue S; Barold SS; Bressolles N; Lanusse S; Clémenty J
Europace; 2003 Oct; 5(4):429-31. PubMed ID: 14753643
[TBL] [Abstract][Full Text] [Related]
15. Cognitive stimulation therapy for Alzheimer's disease: the effect of cognitive stimulation therapy on the progression of mild Alzheimer's disease in patients treated with donepezil.
Matsuda O
Int Psychogeriatr; 2007 Apr; 19(2):241-52. PubMed ID: 17005066
[TBL] [Abstract][Full Text] [Related]
16. Effects of long-term Donepezil therapy on rCBF of Alzheimer's patients.
Nobili F; Vitali P; Canfora M; Girtler N; De Leo C; Mariani G; Pupi A; Rodriguez G
Clin Neurophysiol; 2002 Aug; 113(8):1241-8. PubMed ID: 12140003
[TBL] [Abstract][Full Text] [Related]
17. [Achetylcholinesterase (AChE) inhibition and serum lipokines in Alzheimer's disease: friend or foe?].
Kovacs J; Pakaski M; Juhasz A; Feher A; Drotos G; Fazekas CO; Horvath TL; Janka Z; Kalman J
Neuropsychopharmacol Hung; 2012 Mar; 14(1):19-27. PubMed ID: 22427467
[TBL] [Abstract][Full Text] [Related]
18. Long term safety and efficacy of donepezil in the treatment of dementia in Alzheimer's disease in adults with Down syndrome: open label study.
Prasher VP; Adams C; Holder R;
Int J Geriatr Psychiatry; 2003 Jun; 18(6):549-51. PubMed ID: 12789681
[No Abstract] [Full Text] [Related]
19. Increase of BDNF serum concentration during donepezil treatment of patients with early Alzheimer's disease.
Leyhe T; Stransky E; Eschweiler GW; Buchkremer G; Laske C
Eur Arch Psychiatry Clin Neurosci; 2008 Mar; 258(2):124-8. PubMed ID: 17990049
[TBL] [Abstract][Full Text] [Related]
20. Donepezil-induced cervical dystonia in Alzheimer's disease: a case report and literature review of dystonia due to cholinesterase inhibitors.
Ikeda K; Yanagihashi M; Sawada M; Hanashiro S; Kawabe K; Iwasaki Y
Intern Med; 2014; 53(9):1007-10. PubMed ID: 24785894
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
